| |
|
|
|
|
|
|
|||
|
Blood, Vol. 111, Issue 10, 5101-5108, May 15, 2008
Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selection Files in this Data Supplement:
| |||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||